Literature DB >> 12814915

Differential relaxing responses to particulate or soluble guanylyl cyclase activation on endothelial cells: a mechanism dependent on PKG-I alpha activation by NO/cGMP.

F J Rivero-Vilches1, S de Frutos, M Saura, D Rodriguez-Puyol, M Rodriguez-Puyol.   

Abstract

cGMP is generated in endothelial cells after stimulation of soluble guanylyl cyclase (sGC) by nitric oxide (NO) or of particulate guanylyl cyclase (pGC) by natriuretic peptides (NP). We examined whether localized increases in cytosolic cGMP have distinct regulatory roles on the contraction induced by H2O2 treatment in human umbilical vein endothelial cells. cGMP concentrations and temporal dynamics were different upon NO stimulation of sGC or C-type NP (CNP) activation of pGC and did not correlate with their relaxing effects measured as planar cell surface area after H2O2 challenge. cGMP production due to sGC stimulation was always smaller and more brief than that induced by pGC stimulation with CNP, which was greater and remained elevated longer. The NO effects on cell relaxation were cGMP dependent because they were blocked by sGC inhibition with 1H-(1,2,4)Oxadiazolo(4,3-a)quinoxaline-1-one and mimicked by 8-Br-cGMP. An antagonist of the cGMP-dependent protein kinase type-I (PKG-I) also inhibited the NO-induced effects. The cell contraction induced by H2O2 produces myosin light chain (MLC) phosphorylation and NO prevented it completely, whereas CNP only produced a partial inhibition. Transfection with a dominant negative form of PKG type-I alpha completely reversed the NO-induced effects on MLC phosphorylation, whereas it only partially inhibited the effects due to CNP. Taken together, these results demonstrate that the NO/sGC/cGMP pathway induces endothelial cell relaxation in a more efficient manner than does CNP/pGC/cGMP pathway, an effect that might be related to a selective stimulation of PKG-1 alpha by NO-derived cGMP. Consequently, stimulated PKG-I alpha may phosphorylate important protein targets that are necessary to inhibit the endothelial contractile machinery activated by oxidative stress.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12814915     DOI: 10.1152/ajpcell.00590.2002

Source DB:  PubMed          Journal:  Am J Physiol Cell Physiol        ISSN: 0363-6143            Impact factor:   4.249


  14 in total

1.  Relaxin regulates myofibroblast contractility and protects against lung fibrosis.

Authors:  Xiangwei Huang; Ying Gai; Naiheng Yang; Baogen Lu; Chrishan S Samuel; Victor J Thannickal; Yong Zhou
Journal:  Am J Pathol       Date:  2011-10-06       Impact factor: 4.307

2.  cGMP-dependent protein kinase in regulation of basal tone and in nitroglycerin- and nitric-oxide-induced relaxation in porcine coronary artery.

Authors:  Xue Qin; Xiaoxu Zheng; Hui Qi; Dou Dou; J Usha Raj; Yuansheng Gao
Journal:  Pflugers Arch       Date:  2007-03-22       Impact factor: 3.657

3.  Lactobacillus farciminis treatment suppresses stress induced visceral hypersensitivity: a possible action through interaction with epithelial cell cytoskeleton contraction.

Authors:  A Ait-Belgnaoui; W Han; F Lamine; H Eutamene; J Fioramonti; L Bueno; V Theodorou
Journal:  Gut       Date:  2006-02-28       Impact factor: 23.059

4.  Nitric oxide counters the inhibitory effects of uremic toxin indoxyl sulfate on endothelial cells by governing ERK MAP kinase and myosin light chain activation.

Authors:  Sourabh Kharait; Daniel J Haddad; Matthew L Springer
Journal:  Biochem Biophys Res Commun       Date:  2011-05-20       Impact factor: 3.575

5.  Kruppel-like factor 2 regulates endothelial barrier function.

Authors:  Zhiyong Lin; Viswanath Natesan; Hong Shi; Fei Dong; Daiji Kawanami; Ganapati H Mahabeleshwar; G Brandon Atkins; Lalitha Nayak; Yingjie Cui; James H Finigan; Mukesh K Jain
Journal:  Arterioscler Thromb Vasc Biol       Date:  2010-07-22       Impact factor: 8.311

6.  Pharmacodynamic interaction between intravenous nitroglycerin and oral sacubitril/valsartan (LCZ696) in healthy subjects.

Authors:  Uwe Schuehly; Surya Ayalasomayajula; Jeppe Buchbjerg; Parasar Pal; Georg Golor; Margaret F Prescott; Gangadhar Sunkara; Markus Hinder; Thomas H Langenickel
Journal:  Eur J Clin Pharmacol       Date:  2018-07-04       Impact factor: 2.953

7.  Cyclic guanosine monophosphate compartmentation in rat cardiac myocytes.

Authors:  Liliana R V Castro; Ignacio Verde; Dermot M F Cooper; Rodolphe Fischmeister
Journal:  Circulation       Date:  2006-05-01       Impact factor: 29.690

8.  PKG and PKC Are Down-Regulated during Cardiomyocyte Differentiation from Embryonic Stem Cells: Manipulation of These Pathways Enhances Cardiomyocyte Production.

Authors:  Stephen Mobley; Jessica M Shookhof; Kara Foshay; Michelle Park; G Ian Gallicano
Journal:  Stem Cells Int       Date:  2010-04-26       Impact factor: 5.443

9.  Phosphodiesterase 5 inhibition ameliorates angiontensin II-induced podocyte dysmotility via the protein kinase G-mediated downregulation of TRPC6 activity.

Authors:  Gentzon Hall; Janelle Rowell; Federica Farinelli; Rasheed A Gbadegesin; Peter Lavin; Guanghong Wu; Alison Homstad; Andrew Malone; Thomas Lindsey; Ruiji Jiang; Robert Spurney; Gordon F Tomaselli; David A Kass; Michelle P Winn
Journal:  Am J Physiol Renal Physiol       Date:  2014-04-16

10.  Soluble guanylyl cyclase contributes to ventilator-induced lung injury in mice.

Authors:  Eric P Schmidt; Mahendra Damarla; Otgonchimeg Rentsendorj; Laura E Servinsky; Bing Zhu; Aigul Moldobaeva; Alfredo Gonzalez; Paul M Hassoun; David B Pearse
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2008-10-10       Impact factor: 5.464

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.